PT2694107T - Tratamento para patologias dermatológicas - Google Patents

Tratamento para patologias dermatológicas

Info

Publication number
PT2694107T
PT2694107T PT12765366T PT12765366T PT2694107T PT 2694107 T PT2694107 T PT 2694107T PT 12765366 T PT12765366 T PT 12765366T PT 12765366 T PT12765366 T PT 12765366T PT 2694107 T PT2694107 T PT 2694107T
Authority
PT
Portugal
Prior art keywords
treatment
dermatological pathologies
dermatological
pathologies
Prior art date
Application number
PT12765366T
Other languages
English (en)
Portuguese (pt)
Inventor
Simard John
Original Assignee
Xbiotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xbiotech Inc filed Critical Xbiotech Inc
Publication of PT2694107T publication Critical patent/PT2694107T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/245—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT12765366T 2011-04-01 2012-04-02 Tratamento para patologias dermatológicas PT2694107T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161470538P 2011-04-01 2011-04-01

Publications (1)

Publication Number Publication Date
PT2694107T true PT2694107T (pt) 2018-11-27

Family

ID=46927554

Family Applications (1)

Application Number Title Priority Date Filing Date
PT12765366T PT2694107T (pt) 2011-04-01 2012-04-02 Tratamento para patologias dermatológicas

Country Status (11)

Country Link
US (2) US20120251548A1 (cg-RX-API-DMAC7.html)
EP (2) EP3417879A1 (cg-RX-API-DMAC7.html)
JP (2) JP6062918B2 (cg-RX-API-DMAC7.html)
KR (3) KR102004554B1 (cg-RX-API-DMAC7.html)
CN (2) CN110201157A (cg-RX-API-DMAC7.html)
AU (2) AU2012236106B2 (cg-RX-API-DMAC7.html)
CA (1) CA2831126C (cg-RX-API-DMAC7.html)
DK (1) DK2694107T3 (cg-RX-API-DMAC7.html)
ES (1) ES2697056T3 (cg-RX-API-DMAC7.html)
PT (1) PT2694107T (cg-RX-API-DMAC7.html)
WO (1) WO2012135812A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180086297A (ko) 2010-06-18 2018-07-30 엑스바이오테크, 인크. 관절염 치료
KR101910760B1 (ko) 2010-08-23 2018-10-22 엑스바이오테크, 인크. 종양성 질병들에 대한 치료
US9724409B2 (en) 2011-04-01 2017-08-08 Xbiotech, Inc. Treatment of inflammatory skin disease
EP3417879A1 (en) * 2011-04-01 2018-12-26 XBiotech, Inc Treatment for dermatological pathologies
CA2849710C (en) 2011-09-23 2020-04-28 Xbiotech Inc. Cachexia treatment
US9545441B2 (en) 2012-09-18 2017-01-17 Xbiotech, Inc. Treatment of diabetes
KR20150064091A (ko) * 2012-10-04 2015-06-10 엑스바이오테크, 인크. 정신의학적 병태의 치료법
EP3582813A4 (en) 2017-02-16 2020-12-30 XBiotech, Inc TREATMENT OF SUPPURATIVE HIDRADENITIS
EP4135839A1 (en) * 2020-04-16 2023-02-22 Janssen Biotech, Inc. Treatment of hidradenitis suppurativa
CA3095675A1 (en) * 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin 1 alpha (il-1a)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US7192584B2 (en) * 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
JPH08502300A (ja) 1992-10-14 1996-03-12 スターリング ウィンスロップ アイエヌシー． 治療および診断像形成組成物および方法
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
GB9405021D0 (en) * 1994-03-15 1994-04-27 Unilever Plc Skin treatment composition
US5945576A (en) * 1996-04-05 1999-08-31 Brigham & Women's Hospital, Inc. Mouse model of psoriasis
AU2001294274A1 (en) 2000-10-19 2002-04-29 Kyowa Hakko Kogyo Co., Ltd. Antibody inhibiting VPLF activity
JP4450644B2 (ja) 2003-03-03 2010-04-14 日本化薬株式会社 Ａｍｆ類を有効成分とする医薬製剤
WO2006001967A2 (en) 2004-05-25 2006-01-05 Sloan-Kettering Institute For Cancer Research Migrastatin analogs in the treatment of cancer
US20050276807A1 (en) * 2004-06-15 2005-12-15 Advanced Biotherapy, Inc. Treatment of acne
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
US20090215992A1 (en) 2005-08-19 2009-08-27 Chengbin Wu Dual variable domain immunoglobulin and uses thereof
PT2032606E (pt) 2006-05-30 2014-02-05 Genentech Inc Anticorpos e imunoconjugados e respetivas utilizações
WO2008082651A2 (en) * 2006-12-29 2008-07-10 Abbott Laboratories Dual-specific il-1a/ il-1b antibodies
PL2285409T3 (pl) * 2008-05-30 2016-10-31 Przeciwciała il-1 alfa
JP5976319B2 (ja) * 2008-09-12 2016-08-23 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 病原性単球の標的化
WO2010087972A2 (en) * 2009-01-29 2010-08-05 Abbott Laboratories Il-1 binding proteins
CN103328511B (zh) * 2010-09-10 2016-01-20 埃派斯进有限公司 抗-IL-1β抗体及其使用方法
EP3417879A1 (en) * 2011-04-01 2018-12-26 XBiotech, Inc Treatment for dermatological pathologies
JP5812669B2 (ja) 2011-04-27 2015-11-17 キヤノン株式会社 画像処理装置および画像処理方法およびコンピュータプログラム。

Also Published As

Publication number Publication date
KR20140033036A (ko) 2014-03-17
AU2017201201A1 (en) 2017-04-06
CN110201157A (zh) 2019-09-06
EP3417879A1 (en) 2018-12-26
EP2694107A2 (en) 2014-02-12
ES2697056T3 (es) 2019-01-21
AU2012236106A1 (en) 2013-09-26
KR20200145844A (ko) 2020-12-30
EP2694107B1 (en) 2018-08-22
JP2014509662A (ja) 2014-04-21
US20120251548A1 (en) 2012-10-04
CA2831126A1 (en) 2012-10-04
KR102004554B1 (ko) 2019-10-01
EP2694107A4 (en) 2014-10-01
JP2017014228A (ja) 2017-01-19
KR102326482B1 (ko) 2021-11-17
US20160368982A1 (en) 2016-12-22
AU2012236106B2 (en) 2016-12-08
CN103442733A (zh) 2013-12-11
WO2012135812A2 (en) 2012-10-04
US9902769B2 (en) 2018-02-27
AU2017201201B2 (en) 2018-12-13
DK2694107T3 (en) 2018-12-10
KR20190090046A (ko) 2019-07-31
CA2831126C (en) 2019-11-12
JP6453278B2 (ja) 2019-01-16
JP6062918B2 (ja) 2017-01-18
WO2012135812A3 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
IL262611A (en) Treatment for lipodystrophy
EP2609848A4 (en) Borescope
EP2716207A4 (en) ENDOSCOPE DEVICE
EP2716206A4 (en) ENDOSCOPIC DEVICE
EP2668892A4 (en) Borescope
PT2694107T (pt) Tratamento para patologias dermatológicas
EP2621498A4 (en) COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS
EP2664269A4 (en) Borescope
GB2489487B (en) Applicator for an endoscope
PL2510866T3 (pl) Endoskop
ZA201308117B (en) Avian-based treatment
ZA201308176B (en) Therapeutic treatment
GB201102283D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102267D0 (en) Treatment
GB201102276D0 (en) Treatment
GB201102282D0 (en) Treatment
GB201102284D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102288D0 (en) Treatment
GB201111247D0 (en) Treatment
GB201102263D0 (en) Treatment
GB201102275D0 (en) Treatment
GB201102270D0 (en) Treatment
GB201102273D0 (en) Treatment